432
Views
0
CrossRef citations to date
0
Altmetric
LETTER

Critical Response: “Does the Mutation of Cancer Driver Genes IDH1/2 and CD204 Influence Cancer Metabolism and Tumor Associated Macrophage Recruitment in Tumor Microenvironment” [Letter]

ORCID Icon, &
Pages 41-42 | Received 28 Feb 2023, Accepted 17 Mar 2023, Published online: 20 Mar 2023

References

  • Kurdi M, Mulla N, Katib Y, et al. The cancer driver genes IDH1 and IDH2 and CD204 in WHO-grade 4 astrocytoma: crosstalk between cancer metabolism and tumour associated macrophage recruitment in tumour microenvironment. Biol Targets Ther. 2023;17(February):15–22. doi:10.2147/BTT.S394556
  • Roh J, Im M, Kang JH, Youn BH, Kim W. Long non-coding RNA in glioma: novel genetic players in temozolomide resistance. Animal Cells Syst. 2023;27(1):19–28. doi:10.1080/19768354.2023.2175497
  • Chan AKY, Shi ZF, Li KKW, et al. Combinations of single-gene biomarkers can precisely stratify 1028 adult gliomas for prognostication. Front Oncol. 2022;12(April):1–9. doi:10.3389/fonc.2022.839302
  • Sørensen MD, Dahlrot RH, Boldt HB, Hansen S, Kristensen BW. Tumour-associated microglia/macrophages predict poor prognosis in high-grade gliomas and correlate with an aggressive tumour subtype. Neuropathol Appl Neurobiol. 2018;44(2):185–206. doi:10.1111/nan.12428
  • Kurdi M, Katib Y, Faizo E, et al. Association between CD204-expressed tumor-associated macrophages and MGMT-promoter methylation in the microenvironment of grade 4 astrocytomas. World J Oncol. 2022;13(3):117–125. doi:10.14740/wjon1473
  • Cejalvo T, Gargini R, Segura-Collar B, et al. Immune profiling of gliomas reveals a connection with IDH1/2 mutations, tau function and the vascular phenotype. Cancers. 2020;12(11):1–18. doi:10.3390/cancers12113230